ATE364387T1 - Zellbasierte gentherapie für das lungensystem - Google Patents

Zellbasierte gentherapie für das lungensystem

Info

Publication number
ATE364387T1
ATE364387T1 AT99944205T AT99944205T ATE364387T1 AT E364387 T1 ATE364387 T1 AT E364387T1 AT 99944205 T AT99944205 T AT 99944205T AT 99944205 T AT99944205 T AT 99944205T AT E364387 T1 ATE364387 T1 AT E364387T1
Authority
AT
Austria
Prior art keywords
cell
based gene
gene therapy
patient
circulation
Prior art date
Application number
AT99944205T
Other languages
English (en)
Inventor
Duncan Stewart
Original Assignee
An Go Gen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by An Go Gen Inc filed Critical An Go Gen Inc
Application granted granted Critical
Publication of ATE364387T1 publication Critical patent/ATE364387T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
    • C12Y114/13039—Nitric-oxide synthase (NADPH dependent) (1.14.13.39)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99944205T 1999-09-23 1999-09-23 Zellbasierte gentherapie für das lungensystem ATE364387T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA1999/000869 WO2001021184A1 (en) 1999-09-23 1999-09-23 Cell-based gene therapy for the pulmonary system

Publications (1)

Publication Number Publication Date
ATE364387T1 true ATE364387T1 (de) 2007-07-15

Family

ID=4173386

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944205T ATE364387T1 (de) 1999-09-23 1999-09-23 Zellbasierte gentherapie für das lungensystem

Country Status (11)

Country Link
EP (2) EP1839667B1 (de)
JP (1) JP2003509463A (de)
AT (1) ATE364387T1 (de)
AU (1) AU5724499A (de)
BR (1) BR9917500A (de)
CA (1) CA2383093A1 (de)
DE (1) DE69936320T2 (de)
ES (1) ES2546937T3 (de)
IL (3) IL148826A0 (de)
MX (1) MXPA02003131A (de)
WO (1) WO2001021184A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020191036A1 (en) 2019-03-19 2020-09-24 Fibrogenesis Treatment of chronic obstructive pulmonary disease and lung degeneration using activated fibroblasts and exosome derivatives thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
JPH04507041A (ja) * 1988-12-13 1992-12-10 アメリカ合衆国 遺伝工学により修飾された内皮細胞およびその利用方法
US5240846A (en) * 1989-08-22 1993-08-31 The Regents Of The University Of Michigan Gene therapy vector for cystic fibrosis
WO1992015676A1 (en) * 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Somatic cell gene therapy
AU3429993A (en) * 1992-01-10 1993-08-03 Georgetown University A method of administering genetically engineered endothelial cells to sites of angiogenesis for effecting genetic therapy
CA2086844A1 (en) * 1993-01-07 1994-07-08 Ian D. Dube Method and product of gene transfer into cells
WO1998002170A1 (en) * 1996-07-17 1998-01-22 The General Hospital Corporation Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene
AU729420B2 (en) * 1996-11-01 2001-02-01 Eurogene Limited Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
EP0893493A3 (de) * 1997-07-21 2002-12-04 Aventis Pharma Deutschland GmbH Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
US6147109A (en) * 1997-10-14 2000-11-14 The General Hospital Corporation Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors
CN1295617A (zh) * 1998-02-06 2001-05-16 科莱特诺医疗公司 血管生成因子－血管内皮细胞生长因子vegf的突变体
CA2227425A1 (en) * 1998-03-27 1999-09-27 An-Go-Gen Inc. Cell-based gene therapy
CA2266805C (en) * 1998-03-27 2015-04-28 An-Go-Gen Inc. Cell-based gene therapy in the treatment of pulmonary disorders

Also Published As

Publication number Publication date
DE69936320T2 (de) 2008-02-21
ES2546937T3 (es) 2015-09-30
IL148826A0 (en) 2002-09-12
IL192893A (en) 2014-03-31
EP1220679A1 (de) 2002-07-10
DE69936320D1 (de) 2007-07-26
CA2383093A1 (en) 2001-03-29
WO2001021184A1 (en) 2001-03-29
EP1839667B1 (de) 2015-06-17
AU5724499A (en) 2001-04-24
IL192893A0 (en) 2009-02-11
JP2003509463A (ja) 2003-03-11
EP1839667A2 (de) 2007-10-03
BR9917500A (pt) 2002-05-21
EP1220679B1 (de) 2007-06-13
IL148826A (en) 2010-12-30
MXPA02003131A (es) 2003-08-20
EP1839667A3 (de) 2010-04-14

Similar Documents

Publication Publication Date Title
ATE385810T1 (de) Verwendung von dna oder rna zur herstellung eines medikaments zur behandlung von tumoren
NZ505011A (en) Expression vectors and cell lines expressing VEGF-D and method of treating melanomas
SE9702860L (sv) Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
DE69331526D1 (de) Adenovirus gelenkter gen-transfer zum herz- und glatten vaskularen muskel
ATE319827T1 (de) Polypeptid, das die differenzierung unterdrueckt
IE880380L (en) Deoxyribonucleic acid for the preparation of tissue factor¹protein
FI955552A0 (fi) Adenoviraalisia eläinperäisiä vektoreita ja niiden käyttö geeniterapiassa
NO963742L (no) Fremgangsmåte til å stimulere hematopoese med hemaglobin
ES2043890T3 (es) Nuevo uso medico.
DE69735496D1 (de) Nukleinsäure zur Verwendung in Gentherapie, welche Therapie intestinale Zell-Expression der Genen involviert
GR3034758T3 (en) System and method for transplantation of cells.
ATE71632T1 (de) Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression.
DE60018920D1 (de) Rekombinante adenovirale vektoren, die chimäre fiberproteine exprimieren, für die zellspezifische infektion und genomische integration
NZ505063A (en) Pharmaceutical use of long pentraxin PTX3 in treating tumour conditions
GR3026602T3 (en) Morphogen-induced liver regeneration.
FR2644066B1 (fr) Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques
MD545G2 (ro) Preparat medicamentos
DE69936320D1 (de) Zellbasierte gentherapie für das lungensystem
NZ299257A (en) Treating purulent material (eg pulmonary disease) accumulation in patients using deamidated DNase
WO2003092598A3 (en) Treatment for pompe disease
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
El-Batouty et al. Comparative evaluation of the effects of ultrasonic and ultraviolet irradiation on tissue regeneration
NZ335401A (en) Therapeutic uses of BPI protein products in cystic fibrosis patients
ATE120491T1 (de) Ausgeglichenes, konstitutives, induzierbares transkriptionssystem.
GR3018632T3 (en) Beta-alethine use in cell culture and therapy.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1220679

Country of ref document: EP